Open AccessL-Carnitine Treatment in Incident Hemodialysis Patients
Author(s) -
Lucile Mercadal,
Mathieu Coudert,
Anne Vassault,
Laurence Piéroni,
A. Debure,
Messaoud Ouziala,
Hélène Depreneuf,
Christine Fumeron,
Aude Servais,
Nader Bassilios,
Jacques Bécart,
U. Assogba,
Mahmoud Allouache,
Boussad Bouali,
Nhân Luong,
Marie Paul Dousseaux,
Sophie Tézenas du Montcel,
Gilbert Deray
Publication year - 2012
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.12431211
Subject(s) - medicine , carnitine , hemodialysis , intensive care medicine
L-carnitine levels decrease rapidly and steadily with duration of hemodialysis, and carnitine depletion can impair response to recombinant human erythropoietin (rHuEPO). The study hypothesis was that L-carnitine supplementation during the first year of hemodialysis would improve this response.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom